{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:29:09Z","timestamp":1787783349633,"version":"build-2784847793"},"reference-count":104,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Primary cutaneous lymphomas (PCLs), including cutaneous T-cell lymphomas (CTCL) and primary cutaneous B-cell lymphomas (PCBCL), are a diverse group of non-Hodgkin lymphomas that primarily affect the skin. Radiotherapy (RT) plays a pivotal role in the treatment of these lymphomas, particularly for localized disease, due to its ability to deliver precise, skin-directed treatment. Mycosis fungoides (MF) and S\u00e9zary syndrome (SS), the most common subtypes of CTCL, often require skin-directed therapies such as electron beam therapy and superficial brachytherapy to manage localized lesions. Electron beam therapy, including total skin electron beam therapy (TSEBT), has been utilized for decades, offering high response rates but with the risk of cumulative skin toxicity. Recently, low-dose radiotherapy (LDRT) has gained attention as an effective alternative that reduces toxicity while maintaining durable responses. Superficial brachytherapy is another modality that delivers radiation through custom molds, allowing for homogeneous dosing over complex anatomical areas like the face. Both teleradiotherapy and brachytherapy have demonstrated high complete response rates, with low recurrence rates observed when higher doses are used. In the context of primary cutaneous B-cell lymphomas, such as primary cutaneous marginal zone lymphoma (PCMZL) and primary cutaneous follicle center lymphoma (PCFCL), radiotherapy also offers excellent local control, particularly for indolent subtypes. However, more aggressive subtypes, such as diffuse large B-cell lymphoma, leg type (PCDLBCL-LT), may require systemic therapies in addition to radiation. Overall, teleradiotherapy and brachytherapy are essential components of the therapeutic arsenal for primary cutaneous lymphomas, offering effective disease control with manageable toxicity, while ongoing research focuses on optimizing treatment strategies and exploring novel combinations with systemic therapies.<\/jats:p>","DOI":"10.3390\/cancers17172722","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T11:50:31Z","timestamp":1755863431000},"page":"2722","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeted Radiotherapy in Primary Cutaneous Lymphomas: Precision, Efficacy, and Evolving Strategies"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-8021","authenticated-orcid":false,"given":"Piotr","family":"Sobolewski","sequence":"first","affiliation":[{"name":"Dermatology Clinic, National Institute of Medicine of the Ministry of Interior and Administration, 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1048-2774","authenticated-orcid":false,"given":"Mateusz","family":"Koper","sequence":"additional","affiliation":[{"name":"Dermatology Clinic, National Institute of Medicine of the Ministry of Interior and Administration, 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ciechanowicz","sequence":"additional","affiliation":[{"name":"Dermatology Clinic, National Institute of Medicine of the Ministry of Interior and Administration, 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Walecka","sequence":"additional","affiliation":[{"name":"Dermatology Clinic, National Institute of Medicine of the Ministry of Interior and Administration, 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","article-title":"Modern radiation therapy for primary cutaneous lymphomas: Field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Specht","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_2","first-page":"1703","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_3","first-page":"1600","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-8140(99)00089-4","article-title":"Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases","volume":"52","author":"Kirova","year":"1999","journal-title":"Radiother. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","article-title":"Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma","volume":"55","author":"Eich","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Vitiello, P., Sica, A., Ronchi, A., Caccavale, S., Franco, R., and Argenziano, G. (2020). Primary cutaneous B-cell lymphomas: An update. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00651"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jdv.14549","article-title":"Dermoscopy and the diagnosis of primary cutaneous B-cell lymphoma","volume":"32","author":"Geller","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.det.2015.05.003","article-title":"Diagnosis and management of cutaneous B-cell lymphoma","volume":"33","year":"2015","journal-title":"Dermatol. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO\u2013EORTC classification for cutaneous lymphomas: Comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00066-019-01541-7","article-title":"De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma","volume":"196","author":"Oertel","year":"2020","journal-title":"Strahlenther. Onkol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Girardi","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: Validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1396-0296.2003.01639.x","article-title":"Treatment of patch-stage mycosis fungoides with topical corticosteroids","volume":"16","author":"Zackheim","year":"2003","journal-title":"Dermatol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0889-8588(18)30058-3","article-title":"Electron beam treatment for cutaneous T-cell lymphoma","volume":"9","author":"Jones","year":"1995","journal-title":"Hematol.\/Oncol. Clin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-18-4147","article-title":"Radiotherapy eradicates malignant T cells and is associated with improved survival in early-stage mycosis fungoides","volume":"26","author":"Lowry","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/ajd.13025","article-title":"The role of radiotherapy in the management of non-melanoma skin cancer","volume":"60","author":"Veness","year":"2019","journal-title":"Australas. J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: Current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"115064","DOI":"10.1016\/j.ejca.2024.115064","article-title":"Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group","volume":"212","author":"Elsayad","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"62742","DOI":"10.18632\/oncotarget.18409","article-title":"Improving radiotherapy in cancer treatment: Promises and challenges","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5603\/RPOR.a2021.0013","article-title":"A small case series about safety and effectiveness of a hypofractionated electron beam radiotherapy schedule in five fractions for facial non melanoma skin cancer among frail and elderly patients","volume":"26","author":"Ferini","year":"2021","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kumari, S., Mukherjee, S., Sinha, D., Abdisalaam, S., Krishnan, S., and Asaithamby, A. (2020). Immunomodulatory effects of radiotherapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218151"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41419-023-06211-2","article-title":"Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Barsoumian, H.B., Sezen, D., Menon, H., Younes, A.I., Hu, Y., He, K., Puebla-Osorio, N., Wasley, M., Hsu, E., and Patel, R.R. (2022). High plus low dose radiation strategy in combination with TIGIT and PD1 blockade to promote systemic antitumor responses. Cancers, 14.","DOI":"10.3390\/cancers14010221"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Alard","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kaur, P., and Asea, A. (2012). Radiation-induced effects and the immune system in cancer. Front. Oncol., 2.","DOI":"10.3389\/fonc.2012.00191"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41590-020-0751-0","article-title":"Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0360-3016(99)00547-7","article-title":"Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds","volume":"47","author":"Guix","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_32","first-page":"231","article-title":"Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma","volume":"7","author":"Barker","year":"2015","journal-title":"J. Contemp. Brachyther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5114\/jcb.2020.96864","article-title":"High-dose-rate brachytherapy of primary cutaneous B-cell lymphoma: The first reported case series","volume":"12","author":"Chyrek","year":"2020","journal-title":"J. Contemp. Brachyther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1016\/j.ijrobp.2011.01.023","article-title":"Revisiting low-dose total skin electron beam therapy in mycosis fungoides","volume":"81","author":"Harrison","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2133.2011.10670.x","article-title":"Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: An open-label prospective phase II study","volume":"166","author":"Kamstrup","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2015.01.047","article-title":"Low-dose (10-Gy) total skin electron beam therapy for cutaneous T-cell lymphoma: An open clinical study and pooled data analysis","volume":"92","author":"Kamstrup","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Yosefof, E., Kurman, N., and Yaniv, D. (2023). The role of radiation therapy in the treatment of non-melanoma skin cancer. Cancers, 15.","DOI":"10.3390\/cancers15092408"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/hon.2518","article-title":"Radiotherapy in indolent primary cutaneous B-cell lymphoma","volume":"36","author":"Grapulin","year":"2018","journal-title":"Hematol. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/ajh.26968","article-title":"Cutaneous B-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Hristov","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hon.2919","article-title":"Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"39","author":"Kraft","year":"2021","journal-title":"Hematol. Oncol."},{"key":"ref_41","first-page":"17-0032","article-title":"Primary cutaneous B-cell lymphoma and chronic leg ulcers in a patient with type 2 diabetes","volume":"2017","author":"Mantovani","year":"2017","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Mount, C., Ferraro, D., Gru, A., Bradbury, M., Cornelius, L., and Gay, H. (2014). Treatment of pagetoid reticulosis with intensity modulated radiation therapy. Dermatol. Online J., 20.","DOI":"10.5070\/D32010024251"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/jvc2.205","article-title":"Intralesional and systemic rituximab in the treatment of primary cutaneous B-cell lymphoma","volume":"2","author":"Shahin","year":"2023","journal-title":"JEADV Clin. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff","year":"2007","journal-title":"Arch. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","article-title":"Primary cutaneous B-cell lymphoma treated with radiotherapy: A comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems","volume":"22","author":"Smith","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","article-title":"Low-dose palliative radiotherapy for cutaneous B-and T-cell lymphomas","volume":"74","author":"Neelis","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome\u2013Update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clml.2013.12.018","article-title":"Poorer prognosis of African-American patients with mycosis fungoides: An analysis of the SEER dataset, 1988 to 2008","volume":"14","author":"Nath","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/bjd.12909","article-title":"Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: Where are we now?","volume":"170","author":"Scarisbrick","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2214\/ajr.132.2.261","article-title":"Dose considerations in total skin electron irradiation for mycosis fungoides","volume":"132","author":"Lo","year":"1979","journal-title":"Am. J. Roentgenol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1396-0296.2003.01647.x","article-title":"Mycosis fungoides: Radiation therapy","volume":"16","author":"Hoppe","year":"2003","journal-title":"Dermatol. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0360-3016(94)00590-H","article-title":"Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides","volume":"32","author":"Becker","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0190-9622(96)90499-5","article-title":"Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma","volume":"35","author":"Wilson","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_55","first-page":"725","article-title":"Report of the committee on staging and classification of cutaneous T-cell lymphomas","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat. Rep."},{"key":"ref_56","first-page":"1713","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_57","first-page":"193","article-title":"Combined total skin radiotherapy and immune checkpoint inhibitors: A promising potential treatment for mycosis fungoides and Sezary syndrome","volume":"18","author":"Elsayad","year":"2020","journal-title":"JDDG J. Dtsch. Dermatol. Ges."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0360-3016(97)00553-1","article-title":"Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (mycosis fungoides)","volume":"40","author":"Wilson","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0360-3016(98)00218-1","article-title":"Radiotherapy for unilesional mycosis fungoides","volume":"42","author":"Micaily","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/09546630802516571","article-title":"Minimal stage IA mycosis fungoides. Results of radiotherapy in 15 patients","volume":"20","author":"Piccinno","year":"2009","journal-title":"J. Dermatol. Treat."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","article-title":"Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials","volume":"72","author":"Hoppe","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ijrobp.2017.05.052","article-title":"The results of low-dose total skin electron beam radiation therapy (TSEB) in patients with mycosis fungoides from the UK Cutaneous Lymphoma Group","volume":"99","author":"Morris","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_63","first-page":"4216098","article-title":"Ultra-Low-Dose Radiotherapy for Palliation of Mycosis Fungoides","volume":"2020","author":"Aral","year":"2020","journal-title":"Case Rep. Dermatol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.brachy.2022.09.115","article-title":"PO09: Treatment of Facial Folliculotropic Mycosis Fungoides with High Dose Rate Brachytherapy in Two Fractions","volume":"21","author":"Thawani","year":"2022","journal-title":"Brachy"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5114\/jcb.2017.72607","article-title":"Current status of brachytherapy in cancer treatment\u2013short overview","volume":"9","author":"Skowronek","year":"2017","journal-title":"J. Contemp. Brachyther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/pde.14585","article-title":"Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy","volume":"38","author":"Linggonegoro","year":"2021","journal-title":"Pediatr. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamadermatol.2015.3028","article-title":"Palliative therapy for recalcitrant cutaneous T-cell lymphoma of the hands and feet with low-dose, high dose-rate brachytherapy","volume":"151","author":"Goddard","year":"2015","journal-title":"JAMA Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaad.2012.12.975","article-title":"Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma","volume":"69","author":"DeSimone","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/j.brachy.2014.02.405","article-title":"Dose Fidelity and Conformality for High-Dose-Rate Surface Applicator Brachytherapy for Cutaneous Lymphoma Lesions of the Hands and Feet","volume":"13","author":"Devlin","year":"2014","journal-title":"Brachy"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4236\/ijcm.2015.63020","article-title":"High dose rate (HDR) brachytherapy for mycosis fungoides of the wrist","volume":"6","author":"Shukla","year":"2015","journal-title":"Int. J. Clin. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaad.2019.02.047","article-title":"Management of acute radiation dermatitis: A review of the literature and proposal for treatment algorithm","volume":"81","author":"Rosenthal","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radi.2021.09.006","article-title":"Radiation induced skin reactions during and following radiotherapy: A systematic review of interventions","volume":"28","author":"Burke","year":"2022","journal-title":"Radiography"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4236\/jct.2021.128040","article-title":"Regenerative Medicine to Reduce the Side Effects from Radiotherapy Causing Skin Cancer, Fibrosis, Neuropathic Pain and Hair Loss","volume":"12","author":"Vickers","year":"2021","journal-title":"J. Cancer Ther."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Park, S.-Y., Park, J.M., Kim, J.-i., Choi, C.H., Chun, M., Chang, J.H., and Kim, J.H. (2023). Quantitative radiomics approach to assess acute radiation dermatitis in breast cancer patients. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0293071"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.47191\/ijcsrr\/V6-i12-48","article-title":"A Comparative Study of the Toxicities and Local Recurrence of Conventional External Beam Radiotherapy versus Hypofractionated Radiotherapy in Breast Cancer Patients","volume":"6","author":"Marak","year":"2023","journal-title":"Int. J. Curr. Sci. Res. Rev."},{"key":"ref_76","first-page":"e18147","article-title":"Factors influencing the severity of acute radiation-induced skin and mucosal toxicity in head and neck cancer","volume":"13","author":"Chugh","year":"2021","journal-title":"Cureus"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.12968\/ijpn.2015.21.4.187","article-title":"Management of radiotherapy-induced skin reactions","volume":"21","author":"Trueman","year":"2015","journal-title":"Int. J. Palliat. Nurs."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)","volume":"31","author":"Jd","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_79","first-page":"e23497","article-title":"Feasibility, Tolerance, and Quality of Life for Hypofractionation Versus Conventional Fractionation for Post-mastectomy Radiotherapy in Indian Patients","volume":"14","author":"Malik","year":"2022","journal-title":"Cureus"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"15330338211064719","DOI":"10.1177\/15330338211064719","article-title":"Hypofractionated simultaneous integrated boost radiotherapy versus conventional fractionation radiotherapy of early breast cancer after breast-conserving surgery: Clinical observation and analysis","volume":"20","author":"Dong","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1460396920001077","article-title":"Radiation dermatitis: The evaluation of a new topical therapy for the treatment and prevention of radiation-induced skin damage and moist desquamation: A multicentre UK case cohort study","volume":"20","author":"Johnson","year":"2021","journal-title":"J. Radiother. Pract."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2147\/OTT.S156066","article-title":"The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women","volume":"11","author":"Ding","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5603\/NJO.2022.0017","article-title":"How to manage radiation-induced dermatitis?","volume":"72","author":"Kiprian","year":"2022","journal-title":"Nowotwory. J. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1178223417752772","DOI":"10.1177\/1178223417752772","article-title":"Interest of supportive and barrier protective skin care products in the daily prevention and treatment of cutaneous toxicity during radiotherapy for breast cancer","volume":"12","author":"Berger","year":"2018","journal-title":"Breast Cancer Basic Clin. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"250","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20210577","article-title":"Study of the Various Cutaneous Adverse Reactions to Radiotherapy","volume":"7","author":"Venkatakrishnan","year":"2021","journal-title":"Int. J. Res. Dermatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000330324","article-title":"Irradiation-induced morphea: X-rays as triggers of autoimmunity","volume":"223","author":"Laetsch","year":"2011","journal-title":"Dermatology"},{"key":"ref_87","first-page":"9","article-title":"Late cutaneous effects of a local potent steroid during adjuvant radiotherapy for breast cancer","volume":"7","author":"Ulff","year":"2017","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2147\/CMAR.S52256","article-title":"Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: Recommendations from a multinational expert panel","volume":"5","author":"Bensadoun","year":"2013","journal-title":"Cancer Manag. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S1460396919000724","article-title":"An evaluation of the skincare management of patients receiving radiotherapy for breast cancer","volume":"19","author":"McAlinden","year":"2020","journal-title":"J. Radiother. Pract."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-7-121","article-title":"A double-blind randomised controlled trial of a natural oil-based emulsion (Moogoo Udder Cream\u00ae) containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer","volume":"7","author":"Chan","year":"2012","journal-title":"Radiat. Oncol."},{"key":"ref_91","first-page":"5343","article-title":"Topical management of acute radiation dermatitis in breast cancer patients: A systematic review and meta-analysis","volume":"37","author":"Haruna","year":"2017","journal-title":"Anticancer. Res."},{"key":"ref_92","first-page":"191","article-title":"Education Program to Promote Skin Integrity and Reduce Pain for Patients Receiving External Beam Radiotherapy","volume":"10","author":"Mohamed","year":"2022","journal-title":"Assiut Sci. Nurs. J."},{"key":"ref_93","first-page":"545","article-title":"Skin care management in cancer patients: An evaluation of quality of life and tolerability","volume":"19","author":"Haley","year":"2011","journal-title":"Support. Care Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/acm2.13338","article-title":"Evaluation of skin dose and skin toxicity in patients undergoing intraoperative radiotherapy for early breast cancer","volume":"22","author":"Wong","year":"2021","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Levy, R., and Pope, E. (2019). Primary cutaneous lymphoma. Harper\u2019s Textbook of Pediatric Dermatology, Wiley.","DOI":"10.1002\/9781119142812.ch88"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.adengl.2012.09.016","article-title":"Treatment of cutaneous lymphomas: An update","volume":"103","year":"2012","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (Engl. Ed.)"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5114\/jcb.2024.137357","article-title":"Brachytherapy and 3D printing for skin cancer: A review paper","volume":"16","author":"Poltorak","year":"2024","journal-title":"J. Contemp. Brachyther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"103401","DOI":"10.1016\/j.ejmp.2024.103401","article-title":"Reproducibility and air gap pockets of 3D-printed brachytherapy applicator placement in high-dose-rate skin cancer","volume":"123","author":"Poltorak","year":"2024","journal-title":"Phys. Medica"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5114\/jcb.2024.141420","article-title":"Individualized 3D printing for skin cancer brachytherapy: Development, implementation, clinical applications, and treatment assessment","volume":"16","author":"Poltorak","year":"2024","journal-title":"J. Contemp. Brachyther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1067\/mjd.2002.123482","article-title":"Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group","volume":"47","author":"Jones","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5114\/pdia.2015.54746","article-title":"Brachytherapy in the treatment of skin cancer: An overview","volume":"32","author":"Skowronek","year":"2015","journal-title":"Adv. Dermatol. Allergol.\/Post\u0119py Dermatol. I Alergol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2010.03.027","article-title":"The use of brachytherapy in the treatment of nonmelanoma skin cancer: A review","volume":"65","author":"Alam","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Di Stefani, A., Tagliaferri, L., Lancellotta, V., Fionda, B., Fossati, B., Balducci, M., Federico, F., Hohaus, S., De Simone, C., and Gambacorta, M.A. (2020). The safety of radiotherapy in the treatment of primary cutaneous B-cell lymphoma: A multidisciplinary systematic review. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01133"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/cco.2018.10.01","article-title":"Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment","volume":"8","author":"Jennings","year":"2019","journal-title":"Chin. Clin. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2722\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:33:37Z","timestamp":1760034817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/17\/2722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":104,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cancers17172722"],"URL":"https:\/\/doi.org\/10.3390\/cancers17172722","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}